Results 141 to 150 of about 286,443 (160)
Clogged Arteries, Safety Net Holes: Treating an Underinsured Patient for Homozygous Familial Hypercholesterolemia With Plasmapheresis. [PDF]
CureusPatel P +4 more
europepmc +1 more source
Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series. [PDF]
Orphanet J Rare DisSuppressa P +3 more
europepmc +1 more source
Evinacumab for Homozygous Familial Hypercholesterolemia
New England Journal of Medicine, 2020 BACKGROUND: Homozygous familial hypercholesterolemia is characterized by premature cardiovascular disease caused by markedly elevated levels of low-density lipoprotein (LDL) cholesterol.
Daniel Gaudet, Robert Pordy
exaly +3 more sources
Circulation, 2011 Background— Homozygous familial hypercholesterolemia is an inherited disorder caused by mutations in both low-density lipoprotein receptor alleles, which results in extremely elevated plasma low-density lipoprotein cholesterol ...
Adrian D Marais +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia
Circulation, 2022Dinesh K Kalra, Mounica Vorla
exaly
Evinacumab for the treatment of homozygous familial hypercholesterolemia
Expert Review of Clinical Pharmacology, 2022Junyi Yang
exaly
Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia?
Expert Opinion on Biological Therapy, 2021Sheila A Doggrell
exaly
Marked plaque regression in homozygous familial hypercholesterolemia
Atherosclerosis, 2021Pepijn van Diemen +2 more
exaly